Concepedia

Serotype distribution of invasive Streptococcus pneumoniae in adults 65 years of age and over after the introduction of childhood 13-valent pneumococcal conjugate vaccination programs in Canada, 2010–2016

Walter Demczuk, Irene Martín, Shalini Desai, Averil Griffith, Laurence Caron-Poulin, Brigitte Lefebvre, Allison McGeer, Gregory J. Tyrrell, George G. Zhanel, Jonathan B. Gubbay,

Vaccine · 2018 · 35 citations · 42 references

DOI

Concepts

References

42

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

Cynthia G. Whitney, Monica M. Farley, James L. Hadler et al. · New England Journal of Medicine · 2003 · 2.2K citations · Full text

, , +17

Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine

Tamara Pilishvili, Catherine Lexau, Monica M. Farley et al. · The Journal of Infectious Diseases · 2009 · 1.3K citations · Full text

, , +17

Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults

Marc J. M. Bonten, Susanne M. Huijts, Marieke Bolkenbaas et al. · New England Journal of Medicine · 2015 · 1.2K citations · Full text

, , +17

Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance

Matthew R. Moore, Ruth Link‐Gelles, William Schaffner et al. · The Lancet Infectious Diseases · 2015 · 730 citations · Full text

, , +16

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices.

Sara Tomczyk, Nancy M. Bennett, Charles Stoecker et al. · PubMed · 2014 · 677 citations

, , +17